2.4.1.212: hyaluronan synthase
This is an abbreviated version!
For detailed information about hyaluronan synthase, go to the full flat file.
Word Map on EC 2.4.1.212
-
2.4.1.212
-
glycosaminoglycans
-
collagen
-
polysaccharide
-
keratinocytes
-
cartilage
-
4-methylumbelliferone
-
proteoglycans
-
hyaluronidases
-
chondrocytes
-
dermal
-
mesenchymal
-
pericellular
-
pasteurella
-
udp-glucuronic
-
hyals
-
versican
-
cumulus
-
synovial
-
vocal
-
articular
-
aggrecan
-
osteoarthritis
-
streptococcal
-
udp-n-acetylglucosamine
-
multocida
-
rhamm
-
pyogenes
-
udp-sugars
-
chondroitin
-
glucuronic
-
procollagen
-
synoviocytes
-
cumulus-oocyte
-
decorin
-
udp-glcua
-
photoaging
-
filaggrin
-
equisimilis
-
ha-binding
-
temporomandibular
-
glcua
-
perineuronal
-
ophthalmopathy
-
zooepidemicus
-
uvb-irradiated
-
ha-mediated
-
tnfaip6
-
medicine
-
hyaluronan-binding
-
fibromodulin
-
biglycan
-
analysis
-
synthesis
-
drug development
-
biotechnology
- 2.4.1.212
- glycosaminoglycans
- collagen
- polysaccharide
- keratinocytes
- cartilage
- 4-methylumbelliferone
- proteoglycans
- hyaluronidases
- chondrocytes
-
dermal
- mesenchymal
-
pericellular
- pasteurella
-
udp-glucuronic
-
hyals
- versican
-
cumulus
- synovial
-
vocal
-
articular
- aggrecan
- osteoarthritis
- streptococcal
- udp-n-acetylglucosamine
- multocida
-
rhamm
- pyogenes
- udp-sugars
- chondroitin
-
glucuronic
- procollagen
- synoviocytes
-
cumulus-oocyte
- decorin
- udp-glcua
-
photoaging
- filaggrin
- equisimilis
-
ha-binding
-
temporomandibular
-
glcua
-
perineuronal
- ophthalmopathy
- zooepidemicus
-
uvb-irradiated
-
ha-mediated
-
tnfaip6
- medicine
-
hyaluronan-binding
- fibromodulin
- biglycan
- analysis
- synthesis
- drug development
- biotechnology
Reaction
Synonyms
CHAS2, CHAS3, class I hyaluronan synthase, CPS1, DG42 protein, HA synthase, HA synthase 3, HA1, HA2, HA3, HAS, HAS-1, HAS-2, HAS-3, HAS1, Has2, Has3, hasA, HASs, HsHAS1, HuHAS1, HyaD, hyaluronan synthase, hyaluronan synthase 1, hyaluronan synthase 2, hyaluronan synthase 3, hyaluronan synthase-1, hyaluronan synthase-2, hyaluronan synthases 2, hyaluronan synthethase, hyaluronate synthase, hyaluronate synthetase, hyaluronic acid synthase, hyaluronic acid synthetase, More, PmHAS, seHAS, XHAS1, XHAS2, XHAS3
ECTree
Advanced search results
Inhibitors
Inhibitors on EC 2.4.1.212 - hyaluronan synthase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside
modulates aortic smooth muscle cell motility and adhesive properties through AMP-activated protein kinase, AMPK
AG825
ErbB2 inhibitor, blocks the heregulin-mediated HAS isozyme phosphorylation/activation; ErbB2 inhibitor, blocks the heregulin-mediated HAS isozyme phosphorylation/activation; ErbB2 inhibitor, blocks the heregulin-mediated HAS isozyme phosphorylation/activation
mannose
inhibits HAS because it depletes UDP-GlcNAc in cells; inhibits HAS because it depletes UDP-GlcNAc in cells; inhibits HAS because it depletes UDP-GlcNAc in cells
metformin
modulates aortic smooth muscle cell motility and adhesive properties through AMP-activated protein kinase, AMPK
PEG
-
increasing MW increases the inhibitory effect on the enzyme, overview
thiazolidinedione
ERK inhibitor, blocks the heregulin-mediated HAS isozyme phosphorylation/activation; ERK inhibitor, blocks the heregulin-mediated HAS isozyme phosphorylation/activation; ERK inhibitor, blocks the heregulin-mediated HAS isozyme phosphorylation/activation
UDP-glucuronate
The substrate UDP-GlcA inhibits pmHAS in concentrations above 8 mM
inhibits HAS because it depletes UDPGlcUA in cells; inhibits HAS because it depletes UDPGlcUA in cells; inhibits HAS because it depletes UDPGlcUA in cells
4-Methylumbelliferone
-
changes the localization of the enzyme by preventing its association with the plasma membrane
-
15% inhibition at 5 mM, biphasic inhibition
-
93% reduced activity at 0.05 mM
-
reacts with the Cys residues C226, C262, and C281, but not with C367, binding of substrates UDP-N-acetyl-D-glucosamine, UDP-D-glucuronate, or of product UDP protects the enzyme from inhibition by NEM, level of inhibition of wild-type and mutant enzymes, overview
N-ethylmaleimide
-
biphasic inhibition, about 50% reduced reaction velocity, unaltered Km-value, 70% inhibition at 5 mM
N-ethylmaleimide
-
inhibits wild-type and mutant enzymes by about 90% at 0.2 mM, UDP-N-acetyl-D-glucosamine protects the enzyme best against inactivation by NEM compared to diverse other nucleotide compounds, overview
-
inhibition of wild-type and mutant enzymes, no inhibition of C262 deletion mutant, overview
-
enzyme is inhibited by sulfhydryl-modifying reagents, inhibition mode and mechanism
sulfhydryl reagents
enzyme is inhibited by sulfhydryl-modifying reagents, inhibition mode and mechanism
-
using inhibitors for MEK1/2, U0126, and for PI3K, LY294002, and the SN50 inhibitor, a complete inhibition of HAS2 transcriptional activity and hyaluronan sythesis is observed
-
additional information
AMP-activated protein kinase, AMPK, phosphorylates HAS2 at Thr110, which inhibits its enzymatic activity, and is itself inhibit by Compound C. Isoenzymes HAS1 and HAS3 are not modified by the kinase
-
additional information
-
interleukin-1beta augmented the expression of all 3 isozymes in the uterine cervix of pregnant mice, progesterone inhibited expression of isozymes HAS1 and HAS2
-
additional information
-
using inhibitors for MEK1/2, U0126, and for PI3K, LY294002, and the SN50 inhibitor, a complete inhibition of HAS2 transcriptional activity and hyaluronan sythesis is observed
-
additional information
-
enzyme is more active in 25 mM phosphate buffer than in 50 mM, enzyme is inhibited by increasing viscosity via addition of PEG, glycerol, sucrose or ethylene glycol
-
additional information
-
heating, oxidization or cysteine modification with N-ethylmaleimide inhibit the enzyme
-
additional information
-
HA product size is decreased by increasing concentrations of glycerol
-